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Summary
 
Transgenic expression constructs were employed to identify a cis-acting transcription element
in the T cell receptor (TCR)-
 
g
 
 locus, called HsA, between the V
 
g
 
5 and V
 
g
 
2 genes. In con-
structs lacking the previously defined enhancer (3
 
9
 
E
 
C
 
g
 
1
 
), HsA supports transcription in mature
but not immature T cells in a largely position-independent fashion. 3
 
9
 
E
 
C
 
g
 
1
 
, without HsA, sup-
ports transcription in immature and mature T cells but is subject to severe position effects. To-
gether, the two elements support expression in immature and mature T cells in a copy num-
ber–dependent, position-independent fashion. Furthermore, HsA was necessary for consistent
rearrangement of transgenic recombination substrates. These data suggest that HsA provides
chromatin-opening activity and, together with 3
 
9
 
E
 
C
 
g
 
1
 
, constitutes a T cell–specific locus con-
trol region for the TCR-
 
g
 
 locus.
Key words: T cell receptor 
 
g 
 
• locus control region • V(D)J recombination • transcription • 
enhancer
T
 
and B cell antigen receptor genes are assembled from
variable (V), joining (J), and in some cases diversity
(D) gene segments by the process of V(D)J recombination,
which targets recombination signal sequences adjacent to
each rearranging gene segment (1, 2). Many studies have
demonstrated a strong correlation between the timing or
lineage specificity of V(D)J recombination and prior tran-
scription of the unrearranged genes (“germline transcrip-
tion”) (1). Furthermore, cis-acting DNA elements that
regulate transcription play a decisive role in V(D)J recom-
bination (1). At least one and sometimes two elements with
classical enhancer activity have been identified at each Ig
and TCR locus (3). Transgenic recombination substrates
that lack enhancers almost never rearrange normally (1).
Deletion of the single enhancers identified at the TCR-
 
b
 
and TCR-
 
a
 
 loci caused a profound decrease in V(D)J re-
combination at these loci, as well as reduced receptor gene
transcription (4–6). In loci that have multiple enhancers,
deletion of one enhancer has variable effects. For example,
deletion of the intronic 
 
k
 
 enhancer caused a substantial re-
duction in rearrangement without substantially affecting
transcription of the alleles that did undergo rearrangement
(7). Deletion of the 3
 
9
 
 
 
k
 
 enhancer caused a modest reduc-
tion in both 
 
k
 
 gene rearrangement and transcription (8).
Much evidence suggests that enhancers also play a role in
regulating the timing and cell specificity of rearrangement
(1, 9, 10). In addition, elements in or near the promoters of
V genes can also regulate the timing and cell specificity of
V gene rearrangements (11).
Evidence suggests that sequences in addition to typical
enhancers are often required to obtain high-level transcrip-
tion in transgenic mice. Sequences proximal to the IgH in-
tronic enhancer exhibit chromatin-opening activity that is
important for normal transcription of transgenic heavy
chain genes (12). Similarly, consistent high-level expression
of TCR-
 
a
 
 transgenes required the presence of elements
downstream of the defined enhancer element (13). In both
cases, the combination of the enhancer and the additional
required sequences exhibited features of a locus control re-
gion (LCR),
 
1
 
 a type of regulatory cassette first defined in
the 
 
b
 
 globin locus (14; for review see reference 15). LCRs
promote consistent, tissue-specific transcription in chroma-
tin templates, a property that classical enhancers by them-
selves often lack. Operationally, an LCR is defined as a cis-
acting element that confers tissue-specific, high-level, copy
number–dependent, integration site–independent expres-
sion of a linked gene in transgenic mice. Although LCRs
often contain elements that function as enhancers in tran-
sient transfection assays, sequences in addition to these en-
 
1
 
Abbreviations used in this paper:
 
 DN, double-negative; DP, double-posi-
tive; LCR, locus control region; rr, rearranged; RT, reverse transcriptase;
SP, single-positive. 
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g
 
 Locus
 
hancer elements are often necessary for LCR activity (12,
16–18). It is believed that LCRs function to initiate an
open chromatin configuration in the appropriate cell type,
thereby isolating linked genes from possible negative effects
of neighboring chromatin. Based on their chromatin-alter-
ing properties, LCRs could potentially play a role in the
control of V(D)J recombination.
The C
 
g
 
1 cluster of the murine TCR-
 
g
 
 locus is rela-
tively small, spanning 40–50 kbp, and includes four V re-
gion gene segments (V
 
g
 
5, V
 
g
 
2, V
 
g
 
4, and V
 
g
 
3) that rear-
range to a single J gene segment (J
 
g
 
1). The choice of V
 
g
 
gene for rearrangement is highly developmentally regu-
lated, with V
 
g
 
3 and V
 
g
 
4 predominating in the early fetal
thymus and V
 
g
 
2 predominating later in development (19).
A T cell–specific transcriptional enhancer, denoted here as
3
 
9
 
E
 
C
 
g
 
1
 
, was previously localized 3 kb downstream of C
 
g
 
1
by its capacity to activate reporter gene expression from a
minimal promoter in transient transfection experiments
(20, 21). The 3
 
9
 
E
 
C
 
g
 
1
 
 element was the only enhancer ele-
ment detected with the transient transfection assay within a
17-kb stretch of DNA derived from a rearranged V
 
g
 
2
gene. As a monomer, 3
 
9
 
E
 
C
 
g
 
1
 
 was active only in a few T cell
lines; however, when multimerized, it was active in nearly
every T cell line tested.
Although several 
 
g
 
 gene constructs that contain 3
 
9
 
E
 
C
 
g
 
1
 
underwent transcription in transgenic mice (22–25), it has
not been directly established that 3
 
9
 
E
 
C
 
g
 
1
 
 promotes tran-
scription in templates that are integrated in chromatin, nor
has it been established that 3
 
9
 
E
 
C
 
g
 
1
 
 is the only enhancer-like
element in the locus. Furthermore, the role of 3
 
9
 
E
 
C
 
g
 
1
 
 and
other putative enhancer elements in regulating recombina-
tion at the C
 
g
 
1 locus has not been examined. In this study,
we describe a novel enhancer-like element between the
V
 
g
 
5 and V
 
g
 
2 genes that plays a clear role in driving 
 
g
 
transgene transcription and recombination and that, in com-
bination with 3
 
9
 
E
 
C
 
g
 
1
 
, possesses many properties of an LCR.
 
Materials and Methods
 
Mice.
 
The rearranged (rr)V2H
 
1
 
E
 
1
 
 transgene was previously
described as the 
 
g 
 
transgene containing the EcoRI–SalI fragment
of the G8 TCR-
 
g
 
 gene (22, 25). The rrV2H
 
1
 
E
 
2
 
 transgene was
identical except that the 2.8-kb KpnI–SalI fragment containing
3
 
9
 
E
 
C
 
g
 
1
 
 was removed from the 3
 
9
 
 end. The rrV2H
 
2
 
E
 
1
 
 transgene
lacked the 1.5-kb EcoRI–NcoI fragment containing HsA at the
5
 
9
 
 end. The rrV2H
 
2
 
E
 
2
 
 transgene lacked both of these fragments.
The 
 
g
 
D(H
 
1
 
E
 
1
 
) transgene was assembled from BALB/c DNA
derived from phage clones. It included the 5-kb EcoRI fragment
containing V
 
g
 
2 and HsA and a 15.5-kb MboI fragment contain-
ing J
 
g
 
1, C
 
g
 
1, and 3
 
9
 
E
 
C
 
g
 
1
 
 that extended from 4.8 kb upstream of
J
 
g
 
1 to 4 kb downstream of C
 
g
 
1. Compared with germline DNA,
the transgene lacked 18.5 kb of DNA between V
 
g
 
2 and J
 
g
 
1, in-
cluding the V
 
g
 
3 and V
 
g
 
4 genes. The V
 
g
 
2 gene in the 
 
g
 
D trans-
genics contained an XhoI linker at the ClaI site in the coding re-
gion that disrupted the reading frame and allowed discrimination
between transgenes and endogenous genes. The 
 
g
 
D(H
 
1
 
E
 
2
 
)
transgene was identical to 
 
g
 
D(H
 
1
 
E
 
1
 
) except it lacked the 2.6-kb
KpnI–MboI 3
 
9
 
 fragment containing 3
 
9
 
E
 
C
 
g
 
1
 
. The 
 
g
 
D(H
 
2
 
E
 
1
 
)
transgene lacked the 3.5-kb EcoRI–XbaI 5
 
9
 
 fragment containing
 
HsA. The 
 
gD(H2E2) transgene lacked the 2.6-kb 39 fragment
containing 39ECg1 and a 1.5-kb EcoRI–NcoI fragment contain-
ing HsA. The transgene constructs, free of vector DNA, were in-
jected into fertilized (C57BL/6 3 CBA/J)F2 eggs. Transgenic
founders were either analyzed directly or were backcrossed re-
peatedly to B6 mice (rrV2 lines) or CBA/J mice (gD lines; pur-
chased from the National Cancer Institute, Bethesda, MD) to
generate transgenic lines. Mice were bred and maintained in spe-
cific pathogen-free facilities at the University of California at
Berkeley.
Assay for DNase I Hypersensitive Sites. The DNase I hyper-
sensitive assays were performed on thymocytes and LPS blasts as
described (26) except that the cells were lysed in a saponin solu-
tion (27). The quantities of DNase I (Type IV; Sigma Chemical
Co.) per tube were as follows: 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 12.8,
25, and 50 mg. The control tube contained water. The DNase I
hypersensitive assays on liver were performed as previously de-
scribed (28). LPS blasts were made by incubating spleen cells,
from which CD41 and CD81 cells had been depleted by com-
plement lysis, with 40 mg/ml LPS (Salmonella typhosa; Difco
Labs., Inc.) at a concentration of 2 3 106 cells/ml for 3 d. More
than 90% of the resulting cells stained positive for the B cell
marker B220.
Cell Preparations for Nucleic Acid Analysis. Peripheral T cells
were prepared from a mixture of spleen and lymph node cells by
passing the cells over nylon wool columns. To purify a/b and g/d
T cells, the isolated peripheral T cells were combined with thy-
mocytes, and the mixture was partially depleted of CD4 and
CD8 cells by complement lysis followed by cell sorting with an
Epics Elite flow cytometer (Coulter Immunology) using anti-gd
(GL3–FITC) and anti-ab (H57.597–biotin) antibodies. Fetal
thymus was timed by designating the day of the plug as day 0.
The whole fetal thymus, including the capsule, was used to iso-
late RNA. CD42CD82 double-negative (DN) thymocytes were
prepared by complement lysis of whole thymocytes with anti-
CD4 (RL172) and anti-CD8 (3.168.8 or AD415) antibodies and
a mixture of guinea pig complement (GIBCO BRL) and rabbit
complement followed by isolation of live cells on a Ficoll gra-
dient. CD41CD81 thymocytes (double-positives [DPs]) and
CD41CD82 and CD81CD42 thymocytes (single-positives [SPs])
were sorted on an Epics Elite flow cytometer (Coulter Immunol-
ogy) using anti-CD4 and anti-CD8 antibodies. The enriched DN
populations of the gD lines employed for the analysis of tran-
scription in different developmental stages (see Fig. 4) were not
sorted and hence were only z50% pure. For semiquantitative
transcription analysis of gD lines, DN, DP, and SP thymocytes
were sorted to .99% purity using anti-CD4 and anti-CD8 anti-
bodies.
Nucleic Acid Preparation. Total RNA was prepared by the sin-
gle step method using water-saturated phenol as described (29).
20 mg of tRNA was added as a carrier. Genomic DNA was pre-
pared from defined numbers of cells as described (29). Lambda
DNA (2.5 mg; New England Biolabs, Inc.) was added as carrier.
RNase Protection Assay. RNase protection assays (30) were
performed with a riboprobe generated using T7 RNA poly-
merase and a linearized pKS Bluescript™ vector (Stratagene Inc.)
construct containing the KpnI–BsrI fragment (273 bp) spanning
the V–J junction of the G8 g gene. The control riboprobe spe-
cific for g actin mRNA (31) was generated using SP6 RNA
polymerase. Densitometric analysis was performed using a Phos-
phorImager® (Molecular Dynamics).
Semiquantitative PCR. Serial threefold dilutions of DNA
were prepared in the presence of 50 mg/ml bacteriophage lambda
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DNA (New England Biolabs, Inc.), and PCR reactions were
performed as described (11) with the L2 and J1 primers (32). The
transgene contained an XhoI linker in the V2 coding sequence;
thus, digestion of the products with XhoI distinguished the en-
dogenous product from the transgene product. The sample dilu-
tions were compared with a standard curve prepared with DNA
from the DN2.3 hybridoma (33), which contains two Vg2 rear-
ranged genes and four tubulin genes. A b tubulin PCR was used
to normalize the samples. The bands were visualized by autorad-
iography, and their intensities were measured on a PhosphorIm-
ager®. Reverse transcriptase (RT)-PCR was employed for a par-
allel analysis of transcript levels in the gD transgenic lines. The
procedure was done as described using either oligo-dT or J1
primer for reverse transcription and the L2 and J1 primers (or tu-
bulin primers) for PCR (32), with or without RT, except that 1
mCi a-[32P]dCTP was added during the PCR amplification step,
and 28 cycles of amplification were performed. The PCR prod-
ucts were digested and analyzed as described for the genomic PCR.
Antibodies and Flow Cytometry. Anti–Vg2 TCR (UC3-10A6)
and anti–d TCR (GL3) were purified and conjugated with biotin
and FITC, respectively. Anti-CD8a–Tricolor was purchased
from Caltag Labs., and anti-CD4–Red 613 was from GIBCO
BRL. Unseparated thymocytes from adult mice were stained
with all four antibodies in the first step and streptavidin–PE (Mo-
lecular Probes, Inc.) in the second step. Gated TCR-g/d1
CD42CD82 thymocytes were examined for Vg2 expression on
an Epics XL-MCL flow cytometer (Coulter Immunology).
Results
Recombination and Transcription Occur in the Absence of
39ECg1. Initially, we compared the in vivo activity of two
g transgene constructs consisting of Vg2, 4, and 3 gene
segments upstream of the Jg1-Cg1 genes, all in their germ-
line configurations. The two constructs were identical ex-
cept that one lacked a 2.8-kb 39 fragment that contains
39ECg1 (Fig. 1 A shows a map of the germline Cg1 locus).
We found that several independent transgenic lines of each
type consistently underwent rearrangement of Vg2 to Jg1
in thymocytes and that both constructs were efficiently
transcribed (data not shown; see below for a similar analy-
sis). These data indicated that 39ECg1 is not absolutely re-
quired for either transgene rearrangement or expression
and raised the possibility that the constructs contained a
second cis-acting enhancer-like element. A clue to the site
of such an element came from a previous study of a trans-
gene construct (19L5) containing a rearranged Vg2–
Jg1Cg1 gene lacking 39ECg1 that was not expressed in vivo
(reference 20 and Raulet, D., unpublished data). Com-
pared with the constructs above, 19L5 lacked a 1.5-kb seg-
ment of DNA upstream of Vg2 on its 59 end. These data
raised the possibility that a relevant enhancer element
might lie on this 1.5-kb DNA segment 59 of Vg2.
DNase I Hypersensitive Sites in the Cg1 Locus. Examina-
tion of the region upstream of Vg2 demonstrated a clear
DNase I hypersensitive site, denoted HsA, in adult thy-
mocytes (Fig. 1 B). HsA mapped to the region 3 kb up-
stream of Vg2, corresponding to the 59 region that was absent
from the 19L5 construct compared with the rearrangement
constructs described above. The site was not DNase hyper-
sensitive in B lymphocytes (LPS blasts, 90% B cells) or liver
cells (Fig. 1 B).
In a parallel analysis, the 39ECg1 region was weakly hy-
persensitive in normal adult thymocytes (data not shown).
The DNase hypersensitivity of 39ECg1 (designated HsE) was
more clearly demonstrated in a transgenic line with 15 cop-
ies of an integrated TCR-g transgene, called gB, that con-
sists of 40 kb of contiguous germline DNA from the g lo-
cus (Fig. 1 C; reference 11). HsE was also hypersensitive to
DNase I in B cells of the transgenic mice but was not hy-
persensitive in liver cells. Several other hypersensitive sites,
most of them weak, were also detected in the transgene,
but these have not been corroborated in nontransgenic cells
(data not shown).
HsA and 39ECg1 Function to Enhance g Gene Expression In
Vivo. To systematically investigate the transcription-enhan-
cing activities of HsA and 39ECg1 in vivo, we compared
four transgene constructs containing a prerearranged Vg2–
Figure 1. DNase I hypersensitive (Hs)
sites in the TCR-g locus. (A) Map of the g
locus. Restriction enzyme sites: R, EcoRI;
B, BamHI; and S, SalI. Probes 1 and 2 em-
ployed for Southern analysis are indicated,
as are the locations of HsA and HsE. (B) As-
say for Hs sites upstream of Vg2. DNA
from nuclei treated with twofold increasing
amounts of DNase I starting with 0.2 mg
was digested with EcoRI. Southern blots
were hybridized with probe 1. Unfraction-
ated thymocytes (T), LPS B cell blasts (B),
and liver cells (L) were compared. (C) Assay
for Hs sites downstream of Cg1. Assay was
performed as for B except that the cells
were from a mouse containing 15 copies of
a contiguous g locus transgene (gB), the
DNA was digested with BamHI and SalI,
and probe 2 was employed. Molecular
weight markers (shown as kb) are indicated
to the right of each blot.
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Jg1Cg1 gene (Fig. 2 A). The rrV2H1E1 construct con-
taining both HSA and 39ECg1 was previously described
(25). The rrV2H1E2 construct contained HsA but lacked
the 2.8-kb 39 fragment containing 39ECg1, rrV2H2E1 con-
tained 39ECg1 but lacked a 1.5-kb 59 fragment containing
HsA, and rrV2H2E2 lacked both the 59 and 39 fragments.
Founders were either killed and analyzed directly or bred
to generate transgenic lines. Transgene copy numbers were
determined by Southern blot analysis. In the cases where
founder mice were analyzed directly, we determined trans-
gene copy number in the cells being examined to minimize
the effects of the transgene mosaicism that sometimes oc-
curs in founder animals.
A quantitative RNase protection assay was used to mea-
sure Vg2 transcripts in RNA from peripheral T cells and
thymocytes from the transgenic mice. The riboprobe
spanned the unique V–J junctional region of the transgene,
allowing the specific detection of transgene-encoded tran-
scripts as full length protected products. g Transcript levels
were normalized by inclusion of a control g actin probe in
each reaction. The results demonstrated that the transgene
was efficiently transcribed in peripheral T cells from all
three rrV2H1E1 lines and from all six rrV2H1E2 lines
(Fig. 2 B). Similarly, transgene transcription was detected
in thymocytes from all of these transgenic lines (Fig. 2 B).
Transcription was T cell–specific, as no transcripts could be
detected in B cells or kidney cells from several representa-
tive transgenic lines (data not shown). In contrast to the
transgenes containing HsA, transgene transcription could
not be detected in either peripheral T cells or thymocytes
of the five rrV2H2E2 transgenic lines. Thus, the fragment
containing HsA consistently enhances T cell–specific g gene
expression in chromatin templates in the absence of 39ECg1.
In contrast to the consistent expression of transgenes
containing HsA, sporadic expression was observed in the
case of the rrV2H2E1 transgene, which contained 39ECg1
but not HsA. Of the 14 lines tested, expression was de-
tected in 5 or 6 lines in peripheral T cells and in 7 or 8 lines
in thymocytes (Fig. 2 B). No expression of the transgene
was detected in B cells or kidney cells from several repre-
Figure 2. (A) Schematic depiction of rrV2 constructs. HsA (H) and 39ECg1 (E) are indicated. (B) RNase protection assay with RNA from peripheral T
cells (top panel) and thymocytes (bottom panel) from each transgenic line. The transgene copy number of each line is indicated above each lane. Lanes
containing undigested Vg2 (V2) and actin (Act) probes, tRNA, and RNA from the DN2.3 cell line are indicated. The identities of the protected tran-
scripts are as follows: 1, transgenic Vg2; 2, endogenous Vg2; 3, actin. Endogenous Vg2 is not expressed in a/b lineage cells, which comprise the majority
of peripheral T cells and thymocytes (see text). The double bands in the transgene Vg2 probably represent spliced and unspliced transcript. Ntg, non-
transgenic. (C) Relationship between normalized transcript levels in peripheral T cells and transgene copy numbers. One unit of transcript is defined as
the level from one rearranged Vg2 gene in the DN2.3 cell line. (D) The levels of transcript, corrected for transgene copy number, in thymocytes and pe-
ripheral T cells for each transgenic line. The transgene copy number for each line is shown below the bars.
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sentative transgenic lines (data not shown). Sporadic ex-
pression of the rrV2H2E1 transgene was dependent on the
39 fragment containing 39ECg1 because, as already discussed,
the rrV2H2E2 transgene lacking this fragment was not ex-
pressed in five independent lines. Hence, 39ECg1 can en-
hance transcription in chromatin templates but is subject to
transgene position effects.
To allow quantitative comparisons, transgene expression
levels in peripheral T cells were plotted against transgene
copy number. One unit of transcripts was defined as the
level of transcripts directed by an endogenous rearranged
Vg2 gene. This value was determined by parallel analysis of
the DN2.3 g/d cell line, which contains two rearranged
Vg2 alleles (Fig. 2 B). In transgenic lines that contained
HsA (rrV2H1E1 and rrV2H1E2), the graphs revealed a
roughly proportional relationship between the number of
integrated transgene copies and the levels of transgene ex-
pression (Fig. 2 C). Furthermore, the slope of the graphs
was z1, indicating that the level of transcripts per trans-
gene copy was roughly the same as the level directed by an
endogenous Vg2 gene. Even an rrV2H1E1 transgenic line
with only two transgene copies exhibited a similar level of
transgene expression per copy as the endogenous gene (Fig.
2 D). In contrast, the rrV2H2E1 transgene, which lacked
HsA but contained 39ECg1, was transcribed at detectable
levels in less than half of the lines (Fig. 2, C and D). The
lines where transcripts were detectable were all high-copy
lines. No transcripts were detected in the lines harboring
the rrV2H2E2 construct. These results demonstrated that
the transgenes that contained HsA exhibited position-inde-
pendent, roughly copy number–dependent transcription of
the transgene in peripheral T cells. In contrast, the trans-
gene that contained 39ECg1 but not HsA exhibited severe
position effects.
Transgene Expression in g/d Cells. Transgene expression
in g/d cells was investigated by determining transcript levels
in sorted g/d cells in one transgenic line of each type and
by assessing the effect of the transgene on the percentage of
Vg21 cells among thymic g/d cells in several lines. Abun-
dant transgene transcripts were present in g/d T cells from
the three lines examined, representing an rrV2H1E1 line, a
high-expressing rrV2H2E1 line, and an rrV2H1E2 line
(Fig. 3 A). This result was also confirmed by RT-PCR as-
say using purified peripheral g/d T cells (data not shown).
Similar levels of transcript were found in sorted a/b T cells
from the three lines. The expression of the transgene in a/b
T cells is probably due to the absence from the transgene of
a transcriptional silencer that inhibits expression of endoge-
nous g genes in a/b T cells (24, 34) (see Discussion).
Figure 3. Expression of the transgenes in g/d cells. (A) Transgene ex-
pression in sorted a/b and g/d T cells from one transgenic line represent-
ing each construct. The transgene copy number is noted in parentheses.
The assay employed three different concentrations of DN2.3 RNA.
Identities of the protected bands are listed in the legend for Fig. 2 B. (B)
Effect of the transgenes on the percentage of Vg21 g/d cells in the thy-
mus. Gated CD42CD82 TCR-g/d1 adult thymocytes were examined
for Vg2 expression. The transgene copy numbers and RNA expression
levels in the thymus are indicated next to each histogram. Vg2 expression
by nontransgenic thymic g/d T cells (enriched CD42CD82 cells gated on
CD42CD82 TCR-g/d1 cells) is shown for comparison.
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Flow cytometry was employed to determine the per-
centage of Vg21 thymic g/d cells in transgenic lines of each
type (Fig. 3 B). We chose lines that had the most similar
transgene copy numbers to minimize the effect of gene
dosage. In nontransgenic mice, z35–50% of thymic g/d
cells expressed Vg2. The percentage was unaffected in two
rrV2H2E2 lines (41–48%) but was elevated to 80–94% in
the two rrV2H1E1 transgenic lines. The percentage was
also elevated in two rrV2H1E2 lines (z70%) and two
rrV2H2E1 lines that exhibited high levels of transgene
transcripts in the thymus (z80%). In contrast, two
rrV2H2E1 lines that were expressed poorly at the mRNA
level also showed no enhancement in the percentage of
Vg21 cells (30–37%). Thus, transgene expression at the
mRNA level in bulk populations correlated with Vg2 sur-
face expression in g/d cells. Furthermore, the position ef-
fects exhibited by the rrV2H2E1 transgene in bulk popula-
tions were recapitulated in the analysis of g/d cells.
HsA and 39ECg1 Are Developmentally Regulated. Normal-
ization of the transcript levels determined by RNase pro-
tection to transgene copy number demonstrated that the
rrV2H1E2 transgene was expressed at higher levels in pe-
ripheral T cells than in thymocytes in all six transgenic
lines, by an average of 4.5-fold (Fig. 2 D). In contrast, the
rrV2H2E1 transgene was expressed at lower levels in pe-
ripheral T cells than in thymocytes in all the lines where
expression could be detected, by an average of fivefold. In
the rrV2H1E1 lines, the transcript levels in thymocytes
were similar to the levels in peripheral T cells, with one
low-copy line exhibiting marginally higher (twofold) ex-
pression in thymocytes. These data suggested that HsA and
39ECg1 are differentially regulated in peripheral T cells and
thymocytes.
To clarify the developmental activity of the two ele-
ments, we examined representative lines for transgene ex-
pression during thymocyte ontogeny and in subsets of
adult thymocytes (Fig. 4). The transgene with both elements,
rrV2H1E1, was expressed well in fetal thymocyte popula-
tions from day 14–18 of gestation. Similarly, two rrV2H2E1
lines that exhibited transgene expression in adult thy-
mocytes also exhibited substantial transgene expression in
fetal thymocytes. In contrast, the rrV2H1E2 transgene was
expressed very poorly in fetal thymocytes in both lines
tested. We conclude that the HsA element displays poor
enhancing activity in fetal thymocytes, whereas the 39ECg1
element, when not subject to position effects, evinces rela-
tively strong activity in fetal thymocytes.
Transgene expression levels were also determined in
adult immature CD42CD82 (DN) thymocytes, immature
CD41CD81 (DP) thymocytes, and a mixture of the rel-
atively mature SP CD41CD82 and CD42CD81 thy-
mocytes (Fig. 4). The rrV2H1E1 transgene was expressed
well in all of these cell populations. Consistent with the
ontogeny data, all four rrV2H1E2 transgenics tested exhib-
ited poor expression in immature DN and DP thymocytes
but strong expression in SP thymocytes and peripheral T
cells. In contrast, in two lines where the rrV2H2E1 trans-
gene was expressed well in unseparated thymocytes, ex-
pression was relatively strong in the DN, DP, and SP pop-
ulations but weak in peripheral T cells (Fig. 4). These
results suggest that 39ECg1, when not subject to negative
position effects, functions well as an enhancer in immature
thymocytes. In contrast, HsA by itself does not enhance
transcription in immature thymocytes. As expected, little
or no transgene expression was observed in DN thy-
mocytes from two rrV2H2E1 lines in which the transgene
was expressed poorly in unseparated thymocytes and from
the one rrV2H2E2 line tested (data not shown).
Role in Gene Rearrangement. Four new transgenic re-
combination substrates were prepared to examine the role
of HsA and 39ECg1 in g gene recombination (Fig. 5 A).
Figure 4. Developmental activities of HsA and 39ECg1. (A) RNase pro-
tection assay on RNA from fetal thymocytes collected at the indicated
different days of ontogeny (right) and T cell populations representing var-
ious developmental stages (left). One line representing each construct is
shown, with the transgene copy number noted in parentheses. The popu-
lations are: CD42CD82 thymocytes (DN); CD41CD81 thymocytes
(DP); a mixture of CD41CD82 and CD81CD42 thymocytes (SP); and
peripheral T cells (PerT). The remaining details of the figure are identical
to those in Fig. 2 B. (B) The levels of transcript per transgene copy (same
units as Fig. 2) are shown for the populations representing various stages
of development and ontogeny. Each point represents an individual line.
Varying numbers of lines were tested at each stage/population. Only one
H2E1 line was tested at E14, 17, and 18, and the analyses of g/d versus a/b
expression were only performed on one representative line of each type.
Four H1E2 lines were assayed for DN and DP populations.
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The gD construct consisted of a 5-kb genomic fragment
containing HsA and Vg2 attached to a 15.5-kb genomic
fragment containing Jg1, Cg1, and 39ECg1; gD(H1E2) was
identical to gD except it lacked 2.6 kb of DNA containing
39ECg1; gD(H2E1) contained the 39ECg1 fragment but
lacked 3.5 kb of DNA containing HsA; and gD(H2E2)
lacked the 39ECg1 fragment as well as a 1.5-kb fragment of
DNA encompassing HsA. In all of the transgenes, the Vg2
gene contained a frameshift mutation to prevent expression
of a functional protein. Rearrangement and expression of
the transgenes was determined by semiquantitative PCR or
RT-PCR, respectively, in thymocyte populations that had
been enriched in DN cells (z50% DN thymocytes).
Vg2–Jg1 transgene rearrangements were easily detected
in the single gD transgenic line that was examined (Fig. 5,
B and C). For comparative purposes, a separate analysis
showed that the level of transgene rearrangement was one
half to one third that of endogenous Vg2 gene rearrange-
ment levels after normalizing for gene copy. Approxi-
mately similar levels of rearrangement were detected in five
of the six gD(H1E2) transgenic lines, which lacked 39ECg1;
one line exhibited low levels of rearrangement. These find-
ings corroborated the initial data in which 39ECg1 was not
necessary to support g gene rearrangement in transgenic
substrates. The role of HsA in stimulating recombination
was suggested by the results with the gD(H2E2) transgene,
which was identical to gD(H1E2) except that it lacked the
HsA fragment. Rearrangement was undetectable in three
of these transgenic lines and reduced by a factor of three to
five in the remaining three lines. Hence, although low lev-
els of rearrangement occurred in some transgenic lines in
the absence of both HsA and 39ECg1, the fragment contain-
ing HsA stimulated high levels of rearrangement.
Rearrangement of the gD(H2E1) transgene was approx-
imately normal in one transgenic line, undetectable in two
lines, and reduced severalfold in a fourth line (Fig. 5, B and
C). This pattern of rearrangement, indicating clear position
effects, cannot be clearly distinguished from the pattern ob-
served in the gD(H2E2) lines. Therefore, it is unclear from
these data whether the 39ECg1 element plays a discrete role
in stimulating g gene rearrangement (see Discussion).
Transcripts of the rearranged genes were detected by
RT-PCR in each of the gD, gD(H1E2), and gD(H2E1)
lines where recombination was detected (Fig. 5 B), and the
relative levels were roughly correlated with the extent of
rearrangement. In contrast, no such transcripts were de-
Figure 5. Role of HsA and 39ECg1 in g gene recombination. (A) Schematic representation of the gD transgene recombination substrates. Hatch marks
indicate the internal sites where some genomic DNA was omitted from the constructs. (B) Transgene rearrangement and transcription in enriched popu-
lations of DN thymocytes (z50% pure). Rearrangements of Vg2 to Jg1 were assayed by PCR with L2 and J1 primers on genomic DNA from the indi-
cated transgenic lines. PCR products emanating from the transgene (Tg) or endogenous (E) genes were distinguished by digestion with XhoI, a site
which had been inserted in the transgene Vg2 gene. The transgene copy number is indicated above each lane. DNA from 5000 and 1667 cells was am-
plified for each line. Transcripts of the rearranged genes were assayed in parallel by RT-PCR. (C) Normalized rearrangement levels per transgene copy
are shown. Each bar represents an individual line. The values are based on a more complete titration performed separately (see Materials and Methods).
(D) Transgene transcription in sorted (99% pure) DN, DP, and SP thymocytes from gD(H1E1) and gD(H1E2) lines. A representative RT-PCR assay
using Vg2 rearrangement–specific PCR primers with tubulin PCR as a loading control is shown. PCR was performed on samples serially diluted three-
fold. Only two lower-sample concentrations are shown for DN populations. Transcripts derived from the transgene and endogenous genes were distin-
guished as in B. Endogenous Vg2 genes are not expressed in DP and SP thymocytes. Lower bands below the endogenous transcript (arrow) represent
XhoI-digested genomic transgene DNA contaminant. No significant signals were observed in PCR without RT step in each sorted population.
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tected in the gD(H2E2) lines that exhibited low levels of
rearrangement, supporting the earlier conclusion that tran-
scription of the rearranged genes requires HsA and/or
39ECg1. To confirm that the developmental pattern of
transgene transcription in the gD lines paralleled that of the
rrV2 lines, sorted DN, DP, and SP thymocytes from
gD(H1E1) and gD(H1E2) lines were assayed for tran-
scripts of the rearranged transgene by semiquantitative RT-
PCR (Fig. 5 D). The results demonstrate that transgene ex-
pression was high in each population from the gD(H1E1)
line but was lower in DNs, undetectable in DPs, and high
in SPs from the gD(H1E2) line, consistent with the results
from the rrV2 lines. The weak signal in the DNs of the
gD(H1E2) line is likely derived from the 5–10% of g/d T
cells present in this population, as the transgene transcripts
were hardly detectable in the CD32CD42CD82 popula-
tion of this line (data not shown).
Sequence of HsA. With the use of multiple restriction
enzyme digests, we localized the DNase I hypersensitive
site associated with HsA to a 462-bp PstI–NcoI fragment
(data not shown). Although we have not proven that this
small fragment contains the functional site defined by the
transgenic studies, other studies have shown a colocaliza-
tion of cis-acting functional sites and DNase I hypersensi-
tive sites (35). The sequence of this fragment revealed sev-
eral consensus sites for known transcription factors, including
sites for ebox proteins, myb, gata 3, lef/tcf, stat, and gaga
factors (Fig. 6).
Discussion
In Vivo Enhancer Activity of 39ECg1. The data indicate
that 39ECg1 functions as an enhancer in vivo. In terms of
enhancing transcription, 39ECg1 seems to play a more im-
portant role than HsA in immature thymocytes. DNase I
hypersensitivity of 39ECg1 in thymocytes was easily detected
in transgene templates. The hypersensitivity in B cells may
be due to the absence from the transgene of “silencer ele-
ments” present in the endogenous locus, although we em-
phasize that the transgenes were not expressed in B cells.
The endogenous 39ECg1 site was clearly hypersensitive in a
dendritic epidermal g/d T cell line (Goldman, J., and D.H.
Raulet, unpublished data) but was difficult to detect in thy-
mocytes, perhaps because endogenous g gene expression is
silenced in most thymocytes. Overall, the 39ECg1 element
has the properties of a typical non-LCR enhancer element
in that it is active in transient transfection assays, exhibits
DNase I hypersensitivity, and enhances transcription in
vivo but is subject to transgene position effects.
HsA Functions as an Enhancer In Vivo. The HsA ele-
ment is a T cell–specific enhancer-like element that pro-
motes transcription of rearranged g genes in mature T cells.
In addition, HsA stimulates recombination of transgenic g
rearrangement substrates. HsA was hypersensitive to DNase
I in thymocytes but not in B cells or liver cells.
Although HsA exhibited clear enhancer activity in mature
T cells when integrated as a multicopy transgene, it was de-
void of enhancer activity in transient transfection assays in
the PEER and Jurkat cell lines, in which 39ECg1 was active
(data not shown). Both of these cell lines are unlikely to rep-
resent immature cells where HsA is nonfunctional, because
the Jurkat line, at least, appears to be relatively mature based
on its capacity to produce cytokines after TCR cross-link-
ing. It is possible that HsA only functions with a homolo-
gous (g gene) promoter element or only in the context of
chromatin. Other instances have been reported where an el-
ement enhanced transcription when integrated in chromatin
but not in transient transfection assays (18, 36, 37).
HsA in Combination with 39ECg1 Has Properties of an
LCR. HsA, when combined with 39ECg1 as in the
rrV2H1E1 transgene, confers efficient transgene expression
in cells that normally express g genes, including DN thy-
mocytes and purified g/d cells, but does not drive expres-
sion in non-T cells. The enhanced percentage of Vg21
thymic g/d cells with the various lines of transgenic mice
provides further evidence that the transgenes are indeed
expressed in g/d cells. Significantly, expression of the
rrV2H1E1 transgene was independent of transgene posi-
tion effects, and the level of transgene expression was pro-
portional to the number of transgene copies. Thus, the
combination of HsA and 39ECg1 exhibits several character-
istics of LCRs. We have not demonstrated that these ele-
ments are effective in single transgene copies, as none of
the relevant lines contained just a single copy. However, an
rrV2H1E1 line with two transgene copies exhibited high
levels of transgene expression.
Figure 6. Sequence of the PstI/NcoI
fragment containing HsA. Consensus tran-
scription factor binding sites are underlined
and are numbered as follows: 1, gata 3; 2,
gaga; 3, lef/tcf; 4, stat; 5, ebox; 6, myb.
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Although the rrV2H1E1 transgene was regulated appro-
priately in most respects, it was inappropriately expressed in
a/b lineage T cells, unlike endogenous g genes of this type.
Previous studies provided evidence that the absence of ex-
pression of endogenous g genes in a/b lineage cells is due
to an associated “silencer” element (24). Although the si-
lencer has not been subsequently defined or localized in
detail, we have recently shown that transgenes containing
an additional 10 kb of flanking 39 DNA compared with the
rrV2H1E1 transgene, when present at low copy number,
are strongly downregulated in a/b but not g/d T cells (ref-
erence 34 and Kang, J., and D.H. Raulet, unpublished
data). These data are consistent with the conclusion that
transgene expression in a/b T cells observed here is due to
a lack of cell type–specific repressive elements.
Transgenes containing only HsA or 39ECg1 were clearly
expressed inappropriately. The transgene containing 39ECg1
but not HsA exhibited severe position effects and was not
expressed in a copy number–dependent fashion, suggesting
that 39ECg1 by itself is insufficient to open the chromatin.
The transgene containing HsA but not 39ECg1 was poorly
expressed in some cells in which endogenous g genes are ex-
pressed well, such as DN thymocytes and fetal thymocytes.
Nevertheless, HsA by itself did stimulate transcription in pe-
ripheral T cells in every line tested and was expressed in a
roughly copy number–dependent fashion in peripheral T
cells. The effects of HsA suggest that it may isolate linked
genes from the inhibitory effects of neighboring chromatin.
The putative chromatin-opening activity of HsA is probably
operative even in cells where HsA alone functioned poorly
as an enhancer. In total or DN thymocytes, HsA without
39ECg1 was expressed poorly, and 39ECg1 without HsA was
subject to position effects; together, the elements supported
high-level position-independent expression in both popula-
tions (Figs. 2 and 4). Thus, HsA may relieve position effects
in immature thymocytes, cooperating with 39ECg1 to yield
maximal levels of expression. Consistent with the role of
HsA as a chromatin-opening element, we found that the
39ECg1 site was not DNase I hypersensitive in an rrV2H2E1
transgenic line that expressed the transgene poorly but was
hypersensitive in an rrV2H1E1 transgenic line (data not
shown).
Other LCRs have been shown to involve cooperative
elements that enhance transcription and exhibit chromatin-
opening activity (12, 13, 16, 17, 37–40). Hence, chroma-
tin-opening elements may be at least partially separable
from classical enhancers in several LCRs, including the
TCR-g LCR.
Enhancer Activities of HsA and 39ECg1 Are Differentially De-
velopmentally Regulated. In the absence of 39ECg1, HsA
drove transcription in mature SP thymocytes and periph-
eral T cells but not immature thymocytes. This was true of
all four lines tested. In contrast, 39ECg1 by itself, when not
subject to position effects, drove expression in DN, DP,
and SP thymocytes but did so less well in peripheral T cells.
Correspondingly, 39ECg1 functioned relatively well in fetal
thymocytes. It will be of considerable interest to address
the developmental roles of these two elements in vivo,
where different sets of Vg genes are used in the fetal and
adult stages. Other instances have been reported of lym-
phocyte receptor genes with multiple, developmentally
regulated enhancer elements. For example, both the CD4
and CD8 loci contain elements that seem to function dif-
ferently in mature versus immature T cells (41–47).
Roles of HsA and 39ECg1 in V(D)J Recombination. In ad-
dition to promoting transcription of g genes, our results
with the gD series of recombination substrates indicate a
role for HsA in supporting rearrangement of g genes, even
in the absence of 39ECg1. These results are of interest given
the fact that HsA is a poor enhancer in immature thy-
mocytes, the population in which rearrangement presum-
ably takes place. It will be of interest to assess in future
studies whether rearrangement promoted by HsA in the
absence of 39ECg1 primarily involves the chromatin-open-
ing activity of HsA or is associated with prior transcription
of unrearranged Vg genes. For technical reasons, we have
been unable to address whether such germline transcription
occurs from the transgenes.
The gD(H2E2) transgene underwent weak and sporadic
rearrangement, as did the gD(H2E1) transgene. These data
alone were therefore insufficient to assess the role of 39ECg1
in stimulating g gene rearrangement. The finding that
transgene rearrangement occurs to a limited extent in some
lines lacking both elements is surprising, as enhancer ele-
ments are usually required for V(D)J recombination. It is
possible that the transgene integrated into especially open
chromatin in these lines. Alternatively, it remains possible
that elements in the transgenes other than 39ECg1 and HsA
participate in stimulating g gene rearrangement. However, it
is notable that no transcription of the rearranged transgenes
was detected, confirming the importance of 39ECg1 and HsA
in transcription.
The Unique Location of HsA. All of the enhancer ele-
ments identified to date in antigen receptor loci are located
either downstream of the constant regions or within the
J–C introns. The location of HsA between Vg2 and Vg5 is
therefore a novel scenario for antigen receptor genes. A
ramification of the inter-V region location of HsA is that
rearrangements of Vg5 to Jg1 will delete the element.
Therefore, HsA must be unnecessary for supporting tran-
scription of rearranged Vg5 genes. One possibility is that
HsA is only necessary to initially open the chromatin sur-
rounding the Vg genes and that subsequent maintenance of
an open configuration is controlled by other elements and/
or factors. Alternatively, there may exist additional ele-
ments upstream of the Vg5 gene that support chromatin
opening in the relevant cells. As the Vg5 gene is unusual in
that it is believed to undergo rearrangement preferentially
in intestinal epithelial lymphocytes rather than thymocytes
(48), it would not be surprising if the gene was regulated
differently than the other Vg genes. Finally, it is possible
that the endogenous g locus is sufficiently open in the ab-
sence of HsA for at least some cells to efficiently transcribe
g genes. It will be of interest to explore these possibilities
by deleting HsA and/or 39ECg1 at their endogenous loca-
tions.
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